What else you should know You've probably heard the term "Ozempic face" to describe the changed appearance of people who've lost significant amounts of weight
The company is expanding its manufacturing capabilities in India while broadening global product launches across the United States, Europe, and emerging markets
Future research should integrate longitudinal population studies, mechanistic experiments, and circadian rhythm assessments to determine whether prolactin should be considered a driver, regulator, or biomarker of obesity-related metabolic disorders, thereby providing a theoretical basis for more refined and individualized clinical strategies
Over time, usage increases without medical oversight
In this context, liposomes emerge as a promising nanocarrier, offering unique advantages
Beginning July 1, 2026, eligible members of a Medicare drug plan can get certain GLP-1 weight-loss medications for a flat $50 monthly copay